PEXA is not a high quality stock because the high quality Australian segment is hampered by the International and Digital segments.

From fat-loss fad to preventative medicine for a range of chronic health conditions that result from obesity and other metabolic conditions.

Before I (GrowthGauge here) delve into the FY25 results, it is important to understand the history of events for KME. This article marks the anniversary of my coverage of KME stock, shown below. I ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

Lovisa Holdings Ltd (ASX: LOV) delivered another year of strong global growth in FY 2025, setting the stage for further expansion as a key competitor struggles. Backed by retail doyen and chairman ...

As AI ushers in drastic changes for the future of many professions, the legal sphere has emerged as one space where its use has seen especially concerning consequences. Cases across Australia where ...

I’ve written about IPD Group (ASX: IPG) several times over the last few months, both here on A Rich Life, and on Livewire Markets. I purchased shares in IPD Group between February and April of this ...

Everyone dreams of finding the next WiseTech or Pro Medicus – before they hit the ASX 100. The truth is, today’s market giants started life on the ASX as small caps that most investors overlooked. Do ...

Should negative gearing be disallowed for short-stay rental homes? That’s the argument behind a new housing affordability campaign by homelessness advocacy group, Everybody’s Home. Everybody’s Home ...

A company I have covered many times for this publication, Vysarn (VYS:ASX) reported their FY 2025 earnings on Friday, with headline numbers looking relatively strong off the back of what was a ...

Last week, mining software company RPM Global (ASX: RUL) reported its strong FY 2025 results, prompting the share price to gain more than 20% to around $3.80. A conference call to discuss the results ...

When I wrote about LaserBond (ASX:LBL) on July 14th for A Rich Life here, the share price was around 37 cents. At that time, I asked whether the market was undervaluing the business. I also pointed ...